Player FM 앱으로 오프라인으로 전환하세요!
Trust, Teamwork, and Innovation, with Natalie Nairn, Co-founder and CEO of Cyclera Therapeutics
Manage episode 450018099 series 3509339
This week, I spoke with Natalie Nairn, co-founder and CEO of Cyclera Therapeutics. Natalie is also a Termeer Fellow, and listeners of this podcast know how much I love the Termeer Foundation. We discuss her transition from chemical engineering to biomedical applications. She describes her unexpected path into the fun and volatile startup space, which led to her founding Cyclera. Natalie explains the importance of focusing in biotech development, the promising applications of Cyclera's technology in CNS therapeutics, and the challenges and opportunities in the current funding landscape. She also highlights the value of the Termeer fellowship in her career, the contrast between Boston and Seattle's biotech scenes, and the essential aspects of leadership and team cohesion. Finally, Natalie discusses her future goals for Cyclera and offers valuable advice for aspiring biotech founders.
- Get Natalie's recommended book! The Book of Delights: Essays
- CYpHER: catalytic extracellular targeted protein degradation with high potency and durable effect | Nature Communications
- Connect with Natalie on LinkedIn!
- Learn more about Cyclera Therapeutics
Connect with us!
Subscribe here:
Learn more about Recruitomics Consulting
Check out our reading list
Download our free startup resources guide to grow your biotech efficiently
If you're on the job market, visit the Collaboratory Career Hub
00:00 Introduction and Early Aspirations
00:33 Journey into Biomedical Engineering
01:19 First Startup Experience
03:40 Founding Cyclera
05:02 Focus on CNS Therapeutics
13:35 Challenges and Strategies in Biotech
15:39 The Termeer Foundation Fellowship
21:26 Biotech Networks: Boston vs. Seattle
26:50 Future of Cyclera and Personalized Medicine
32:45 Conclusion and Final Thoughts
53 에피소드
Manage episode 450018099 series 3509339
This week, I spoke with Natalie Nairn, co-founder and CEO of Cyclera Therapeutics. Natalie is also a Termeer Fellow, and listeners of this podcast know how much I love the Termeer Foundation. We discuss her transition from chemical engineering to biomedical applications. She describes her unexpected path into the fun and volatile startup space, which led to her founding Cyclera. Natalie explains the importance of focusing in biotech development, the promising applications of Cyclera's technology in CNS therapeutics, and the challenges and opportunities in the current funding landscape. She also highlights the value of the Termeer fellowship in her career, the contrast between Boston and Seattle's biotech scenes, and the essential aspects of leadership and team cohesion. Finally, Natalie discusses her future goals for Cyclera and offers valuable advice for aspiring biotech founders.
- Get Natalie's recommended book! The Book of Delights: Essays
- CYpHER: catalytic extracellular targeted protein degradation with high potency and durable effect | Nature Communications
- Connect with Natalie on LinkedIn!
- Learn more about Cyclera Therapeutics
Connect with us!
Subscribe here:
Learn more about Recruitomics Consulting
Check out our reading list
Download our free startup resources guide to grow your biotech efficiently
If you're on the job market, visit the Collaboratory Career Hub
00:00 Introduction and Early Aspirations
00:33 Journey into Biomedical Engineering
01:19 First Startup Experience
03:40 Founding Cyclera
05:02 Focus on CNS Therapeutics
13:35 Challenges and Strategies in Biotech
15:39 The Termeer Foundation Fellowship
21:26 Biotech Networks: Boston vs. Seattle
26:50 Future of Cyclera and Personalized Medicine
32:45 Conclusion and Final Thoughts
53 에피소드
모든 에피소드
×플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.